A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition

被引:64
|
作者
Mahoney, Christopher E. [1 ]
Pirman, David [1 ]
Chubukov, Victor [1 ]
Sleger, Taryn [1 ]
Hayes, Sebastian [1 ]
Fan, Zi Peng [1 ]
Allen, Eric L. [1 ]
Chen, Ying [2 ]
Huang, Lingling [2 ]
Liu, Meina [2 ]
Zhang, Yingjia [2 ]
McDonald, Gabrielle [1 ]
Narayanaswamy, Rohini [1 ]
Choe, Sung [1 ]
Chen, Yue [1 ]
Gross, Stefan [1 ]
Cianchetta, Giovanni [1 ]
Padyana, Anil K. [1 ]
Murray, Stuart [1 ]
Liu, Wei [1 ]
Marks, Kevin M. [1 ]
Murtie, Joshua [1 ]
Dorsch, Marion [1 ]
Jin, Shengfang [1 ]
Nagaraja, Nelamangala [1 ]
Biller, Scott A. [1 ]
Roddy, Thomas [1 ]
Popovici-Muller, Janeta [1 ,3 ]
Smolen, Gromoslaw A. [1 ,4 ]
机构
[1] Agios Pharmaceut, 88 Sidney St, Cambridge, MA 02139 USA
[2] Shanghai ChemPartner Co Ltd, 998 Halei Rd, Shanghai 201203, Peoples R China
[3] Decibel Therapeut, 1325 Boylston St,Suite 500, Boston, MA 02215 USA
[4] Celsius Therapeut, 215 First St, Cambridge, MA 02142 USA
关键词
SQUALENE EPOXIDASE; LUNG-CANCER; CHOLESTEROL; METABOLISM; SENSITIVITY; ONCOGENE; ASCL1; LEADS; D2O;
D O I
10.1038/s41467-018-07959-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aberrant metabolism of cancer cells is well appreciated, but the identification of cancer subsets with specific metabolic vulnerabilities remains challenging. We conducted a chemical biology screen and identified a subset of neuroendocrine tumors displaying a striking pattern of sensitivity to inhibition of the cholesterol biosynthetic pathway enzyme squalene epoxidase (SQLE). Using a variety of orthogonal approaches, we demonstrate that sensitivity to SQLE inhibition results not from cholesterol biosynthesis pathway inhibition, but rather surprisingly from the specific and toxic accumulation of the SQLE substrate, squalene. These findings highlight SQLE as a potential therapeutic target in a subset of neuroendocrine tumors, particularly small cell lung cancers.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Genome-Wide CRISPR Screen Identifies KEAP1 Perturbation as a Vulnerability of ARID1A-Deficient Cells
    Fournier, Louis-Alexandre
    Kalantari, Forouh
    Wells, James P.
    Lee, Joon Seon
    Trigo-Gonzalez, Genny
    Moksa, Michelle M.
    Smith, Theodore
    White, Justin
    Shanks, Alynn
    Wang, Siyun L.
    Su, Edmund
    Wang, Yemin
    Huntsman, David G.
    Hirst, Martin
    Stirling, Peter C.
    CANCERS, 2024, 16 (17)
  • [32] A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer
    Ware, Kathryn E.
    Thomas, Beatrice C.
    Olawuni, Pelumi
    Sheth, Maya U.
    Hawkey, Nathan
    Yeshwanth, M.
    Miller, Brian C.
    Vietor, Katherine J.
    Jolly, Mohit Kumar
    Kim, So Young
    Armstrong, Andrew J.
    Somarelli, Jason A.
    CANCER RESEARCH, 2023, 83 (11)
  • [33] A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer
    Ware, Kathryn E.
    Thomas, Beatrice C.
    Olawuni, Pelumi D.
    Sheth, Maya U.
    Hawkey, Nathan
    Yeshwanth, M.
    Miller, Brian C.
    Vietor, Katherine J.
    Jolly, Mohit Kumar
    Kim, So Young
    Armstrong, Andrew J.
    Somarelli, Jason A.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [34] MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
    Mollaoglu, Gurkan
    Guthrie, Matthew R.
    Boehm, Stefanie
    Braegelmann, Johannes
    Can, Ismail
    Ballieu, Paul M.
    Marx, Annika
    George, Julie
    Heinen, Christine
    Chalishazar, Milind D.
    Cheng, Haixia
    Ireland, Abbie S.
    Denning, Kendall E.
    Mukhopadhyay, Anandaroop
    Vahrenkamp, Jeffery M.
    Berrett, Kristofer C.
    Mosbruger, Timothy L.
    Wang, Jun
    Kohan, Jessica L.
    Salama, Mohamed E.
    Witt, Benjamin L.
    Peifer, Martin
    Thomas, Roman K.
    Gertz, Jason
    Johnson, Jane E.
    Gazdar, Adi F.
    Wechsler-Reya, Robert J.
    Sos, Martin L.
    Oliver, Trudy G.
    CANCER CELL, 2017, 31 (02) : 270 - 285
  • [35] Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells
    Saraon, Punit
    Snider, Jamie
    Schormann, Wiebke
    Rai, Ankit
    Radulovich, Nikolina
    Sanchez-Osuna, Maria
    Coulombe-Huntington, Jasmin
    Huard, Caroline
    Mohammed, Mohammed
    Lima-Fernandes, Evelyne
    Theriault, Brigitte
    Halabelian, Levon
    Chan, Manuel
    Joshi, Dhananjay
    Drecun, Luka
    Yao, Zhong
    Pathmanathan, Shivanthy
    Wong, Victoria
    Lyakisheva, Anna
    Aboualizadeh, Farzaneh
    Niu, Li
    Li, Fengling
    Kiyota, Taira
    Subramanian, Ratheesh
    Joseph, Babu
    Aman, Ahmed
    Prakesch, Michael
    Isaac, Methvin
    Mamai, Ahmed
    Poda, Gennady
    Vedadi, Masoud
    Marcellus, Richard
    Uehling, David
    Leighl, Natasha
    Sacher, Adrian
    Samarzija, Miroslav
    Jakopovic, Marko
    Arrowsmith, Cheryl
    Tyers, Mike
    Tsao, Ming-Sound
    Andrews, David
    Al-awar, Rima
    Stagljar, Igor
    JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (23)
  • [36] A Yeast-Based Chemical Screen Identifies a PDE Inhibitor That Elevates Steroidogenesis in Mouse Leydig Cells via PDE8 and PDE4 Inhibition
    Demirbas, Didem
    Wyman, Arlene R.
    Shimizu-Albergine, Masami
    Cakici, Ozgur
    Beavo, Joseph A.
    Hoffman, Charles S.
    PLOS ONE, 2013, 8 (08):
  • [37] Small-Molecule Screen Identifies&IT De Novo&IT Nucleotide Synthesis as a Vulnerability of Cells Lacking SIRT3
    Herrera, Karina N. Gonzalez
    Zaganjor, Elma
    Ishikawa, Yoshinori
    Spinelli, Jessica B.
    Yoon, Haejin
    Lin, Jia-Ren
    Satterstrom, F. Kyle
    Ringel, Alison
    Mulei, Stacy
    Souza, Amanda
    Gorham, Joshua M.
    Benson, Craig C.
    Seidman, Jonathan G.
    Sorger, Peter K.
    Clish, Clary B.
    Haigis, Marcia C.
    CELL REPORTS, 2018, 22 (08): : 1945 - 1955
  • [38] A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells
    Bhattacharjee, V.
    Zhou, Y.
    Yen, T. J.
    CELL CYCLE, 2014, 13 (24) : 3839 - 3856
  • [39] Synthetic lethal CRISPR screen identifies a cancer cell-intrinsic role of PD-L1 in regulation of vulnerability to ferroptosis
    Feng, Yang-Ying-Fan
    Li, Yi-Cun
    Liu, Hai-Ming
    Xu, Rui
    Liu, Yu-Tong
    Zhang, Wei
    Yang, Hong-Yu
    Chen, Gang
    CELL REPORTS, 2024, 43 (07):
  • [40] A novel high throughput screen identifies senescence-inducing activity of diaziquone in prostate cancer cells
    Ewald, J.
    Almassi, N.
    Desotelle, J. A.
    Laurilae, T. A. J.
    Jarrard, D. F.
    BJU INTERNATIONAL, 2007, 100 : 24 - 24